Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

Cell

Volumn 140, Issue 2, 2010, Pages 197-208

  Park, Eek Joong ^a   Lee, Jun Hee ^a   Yu, Guann Yi ^a   He, Guobin ^a   Ali, Syed Raza ^a   Holzer, Ryan G ^a   Österreicher, Christoph H ^a,b   Takahashi, Hiroyuki ^a   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

CELLBIO; HUMDISEASE; SIGNALING

Indexed keywords

DIETHYLNITROSAMINE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVATION; EXPERIMENTAL NEOPLASM; FEMALE; GENETIC ASSOCIATION; GENETIC DISORDER; HEPATITIS; LIPID STORAGE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

MUS;

EID: 74549167737     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.12.052     Document Type: Article

References (53)

1. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., and Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005) 191-198
2. Bastard J.P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., and Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85 (2000) 3338-3342
3. Bianchini F., Kaaks R., and Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 3 (2002) 565-574
4. Bisgaard H.C., and Thorgeirsson S.S. Hepatic regeneration. The role of regeneration in pathogenesis of chronic liver diseases. Clin. Lab. Med. 16 (1996) 325-339
5. Bromberg J., and Wang T.C. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15 (2009) 79-80
6. Caldwell S.H., Crespo D.M., Kang H.S., and Al-Osaimi A.M. Obesity and hepatocellular carcinoma. Gastroenterology 127 (2004) S97-S103
7. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4 (2004) 579-591
8. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 (2003) 1625-1638
9. Calvisi D.F., Ladu S., Gorden A., Farina M., Conner E.A., Lee J.S., Factor V.M., and Thorgeirsson S.S. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 130 (2006) 1117-1128
10. Di Gregorio G.B., Westergren R., Enerback S., Lu T., and Kern P.A. Expression of FOXC2 in adipose and muscle and its association with whole body insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E799-E803
11. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 (2007) 2557-2576
12. Eriksen K.W., Kaltoft K., Mikkelsen G., Nielsen M., Zhang Q., Geisler C., Nissen M.H., Ropke C., Wasik M.A., and Odum N. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia 15 (2001) 787-793
13. Fausto N. Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin. Liver Dis. 19 (1999) 243-252
14. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
15. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 (1998) 847-850
16. Friedman J.M., Leibel R.L., Siegel D.S., Walsh J., and Bahary N. Molecular mapping of the mouse ob mutation. Genomics 11 (1991) 1054-1062
17. Grivennikov S., Karin E., Terzic J., Mucida D., Yu G.Y., Vallabhapurapu S., Scheller J., Rose-John S., Cheroutre H., Eckmann L., et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15 (2009) 103-113
18. Guertin D.A., and Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 12 (2007) 9-22
19. He G., Yu G.Y., Temkin V., Ogata H., Kuntzen C., Sakurai T., Sieghart W., Peck-Radosavljevic M., Leffert H.L., and Karin M. Hepatocyte IKKβ/NF-κB inhibits tumor promotion and progression by preventing oxidative stress driven STAT3 activation. Cancer Cell (2010) in press
20. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., and Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
21. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
22. Hui L., Bakiri L., Mairhorfer A., Schweifer N., Haslinger C., Kenner L., Komnenovic V., Scheuch H., Beug H., and Wagner E.F. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat. Genet. 39 (2007) 741-749
23. Johansson M., Denardo D.G., and Coussens L.M. Polarized immune responses differentially regulate cancer development. Immunol. Rev. 222 (2008) 145-154
24. Kamimura D., Ishihara K., and Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149 (2003) 1-38
25. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
26. Li S., Ye L., Yu X., Xu B., Li K., Zhu X., Liu H., Wu X., and Kong L. Hepatitis C virus NS4B induces unfolded protein response and endoplasmic reticulum overload response-dependent NF-kappaB activation. Virology 391 (2009) 257-264
27. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117 (2007) 1175-1183
28. Luedde T., Beraza N., Kotsikoris V., van Loo G., Nenci A., De Vos R., Roskams T., Trautwein C., and Pasparakis M. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11 (2007) 119-132
29. Maeda S., Kamata H., Luo J.L., Leffert H., and Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121 (2005) 977-990
30. Mantovani A., Allavena P., Sica A., and Balkwill F. Cancer-related inflammation. Nature 454 (2008) 436-444
31. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., and Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82 (1997) 4196-4200
32. Nakagawa H., Maeda S., Yoshida H., Tateishi R., Masuzaki R., Ohki T., Hayakawa Y., Kinoshita H., Yamakado M., Kato N., et al. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differences. Int. J. Cancer 125 (2009) 2264-2269
33. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., and Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317 (2007) 121-124
34. Nonogaki K., Fuller G.M., Fuentes N.L., Moser A.H., Staprans I., Grunfeld C., and Feingold K.R. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136 (1995) 2143-2149
35. Parekh S., and Anania F.A. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 132 (2007) 2191-2207
36. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., and Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 (1995) 540-543
37. Rebouissou S., Amessou M., Couchy G., Poussin K., Imbeaud S., Pilati C., Izard T., Balabaud C., Bioulac-Sage P., and Zucman-Rossi J. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457 (2009) 200-204
38. Sakurai T., Maeda S., Chang L., and Karin M. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl. Acad. Sci. USA 103 (2006) 10544-10551
39. Sakurai T., He G., Matsuzawa A., Yu G.Y., Maeda S., Hardiman G., and Karin M. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14 (2008) 156-165
40. Sheweita S.A., and Tilmisany A.K. Cancer and phase II drug-metabolizing enzymes. Curr. Drug Metab. 4 (2003) 45-58
41. Shoelson S.E., Herrero L., and Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 132 (2007) 2169-2180
42. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J.M., et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 6 (2007) 386-397
43. Tilg H., Wilmer A., Vogel W., Herold M., Nolchen B., Judmaier G., and Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103 (1992) 264-274
44. Tremblay F., Brule S., Hee Um S., Li Y., Masuda K., Roden M., Sun X.J., Krebs M., Polakiewicz R.D., Thomas G., et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 104 (2007) 14056-14061
45. Trikha M., Corringham R., Klein B., and Rossi J.F. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin. Cancer Res. 9 (2003) 4653-4665
46. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
47. Vesselinovitch S.D., and Mihailovich N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res. 43 (1983) 4253-4259
48. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., and Jansson J.O. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8 (2002) 75-79
49. Wang T., and Weinman S.A. Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J. Gastroenterol. Hepatol. 21 Suppl 3 (2006) S34-S37
50. Wang Y., Ausman L.M., Greenberg A.S., Russell R.M., and Wang X.D. Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats. Int. J. Cancer 124 (2009) 540-546
51. Ward J.M., Diwan B.A., Ohshima M., Hu H., Schuller H.M., and Rice J.M. Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. Environ. Health Perspect. 65 (1986) 279-291
52. Wong V.W., Yu J., Cheng A.S., Wong G.L., Chan H.Y., Chu E.S., Ng E.K., Chan F.K., Sung J.J., and Chan H.L. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int. J. Cancer 124 (2009) 2766-2770
53. Wunderlich F.T., Luedde T., Singer S., Schmidt-Supprian M., Baumgartl J., Schirmacher P., Pasparakis M., and Bruning J.C. Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proc. Natl. Acad. Sci. USA 105 (2008) 1297-1302